Few Ovarian Cancer Patients Get Recommended Genetic Tests that Could Guide Care, Study Shows

Few Ovarian Cancer Patients Get Recommended Genetic Tests that Could Guide Care, Study Shows
Too few women with ovarian cancer and breast cancer are getting the recommended genetic tests that help evaluate their risk of developing other cancers – which could guide changes in their clinical care – according to a population-based study done in California and Georgia. The discrepancy is particularly strong for women with ovarian cancer, who are “dramatically undertested,” according to researchers from the Stanford University School of Medicine who led the study. Less than one third of women with this disease had genetic tests, contrasting with national guidelines recommending genetic testing for all women with the most common form of ovarian cancer. The study also shows the gap between genetic testing recommendations and practice was worst among black women, those with Medicaid or no insurance, and those living in poorer areas. The findings appeared in the study, “Genetic Testing and Results in a Population-Based Cohort of Breast Cancer and Ovarian Cancer Patients,” published in the Journal of Clinical Oncology
Subscribe or to access all post and page content.